Scott Wilson Curtis, Executive Vice-President at Antibe Therapeutics, holds 115.00K shares in Antibe Therapeutics (Ticker: ATBPF). Most recently, Scott Wilson Curtis Bought $15,000 shares of Antibe Therapeutics on Mar 08, 2024 for an estimated value of 7.80K.